Moxifloxacin: Physical-chemical and Microbiological Analytical Methods in the Context of Green Analytical Chemistry

Author:

da Silva Thaisa Alves Celedonio1,Lustosa Isadora Alves1,Kogawa Ana Carolina1

Affiliation:

1. Department of Pharmacy, Faculty of Pharmacy, Federal University of Goiás, Goiânia, Brazil

Abstract

Abstract: Moxifloxacin (MOX) is a fourth-generation fluoroquinolone used in the form of tablets, infusion solutions and ophthalmic solutions. It does not have a physical-chemical or microbiological analytical method described in an official compendium. However, the literature shows some analysis methods for pharmaceuticals and biological matrices. In this context, the objective is to show the analytical methods present in the literature for the investigation of MOX by physical-chemical and microbiological techniques, as well as discussing them according to the requirements of current pharmaceutical analyses and green analytical chemistry. Among the physical-chemical methods present in the literature for MOX evaluation, 33% are HPLC, 21% are UV-Vis and 17% are capillary electrophoresis. On the other hand, among the microbiological methods, all of them are based on diffusion in agar. There is still scope in the literature to incorporate new and improved analytical methods for MOX evaluation, which adopt the concepts of green and sustainable analytical chemistry, either by using less (or not using) toxic organic solvents, reducing waste generation or even reducing the analysis time according to the intended objectives.

Publisher

Bentham Science Publishers Ltd.

Subject

Drug Discovery,Pharmacology

Reference57 articles.

1. Gunda R.K.; Kumar J.N.S.; Formulation development and evaluation of moxifloxacin.HCL fast dissolving tablets. pharmaceutical methods. Pharm Methods 2017,8(2),160-167

2. Naidoo A.; Ramsuran V.; Chirehwa M.; Denti P.; McIlleron H.; Naidoo K.; Yende-Zuma N.; Singh R.; Ngcapu S.; Chaudhry M.; Pepper M.S.; Padayatchi N.; Effect of genetic variation in UGT1A and ABCB1 on moxifloxacin pharmacokinetics in South African patients with tuberculosis. Pharmacogenomics 2018,19(1),17-29

3. Naqvi G.R.; Naqvi B.S.; Shoaib H.M.; Ali H.; Zafar F.; Parveen S.; Saeed R.; Naz S.; Khan Z.; Naqvi T.S.; Alam N.; Pharmaceutical surveillance study of moxifloxacin formulations: therapeutic perspective in terms of quality and efficacy. Lat Am J Pharm 2018,37(6),1104-1114

4. European Pharmacopeia 2019

5. United States Convention Inc United States Pharmacopeia2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3